Pathogenicity evaluation of coding germline variants identifies rare alleles enriched in hematological patients of a founder population
View ORCID ProfileJessica R. Koski, View ORCID ProfileLaura Langohr, Tuulia Räisänen, View ORCID ProfileAtte K. Lahtinen, View ORCID ProfileMarja Hakkarainen, View ORCID ProfileCaroline A. Heckman, View ORCID ProfileUlla Wartiovaara-Kautto, View ORCID ProfileEsa Pitkänen, View ORCID ProfileOuti Kilpivaara
doi: https://doi.org/10.1101/2024.10.23.24315723
Jessica R. Koski
1Applied Tumor Genomics, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
2Department of Medical and Clinical Genetics, Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Laura Langohr
3Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland
2Department of Medical and Clinical Genetics, Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland
1Applied Tumor Genomics, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
4iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland
Tuulia Räisänen
1Applied Tumor Genomics, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
2Department of Medical and Clinical Genetics, Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Atte K. Lahtinen
1Applied Tumor Genomics, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
2Department of Medical and Clinical Genetics, Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Marja Hakkarainen
1Applied Tumor Genomics, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
2Department of Medical and Clinical Genetics, Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland
5Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki, Finland
Caroline A. Heckman
3Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland
4iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland
Ulla Wartiovaara-Kautto
1Applied Tumor Genomics, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
2Department of Medical and Clinical Genetics, Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland
5Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki, Finland
Esa Pitkänen
3Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland
1Applied Tumor Genomics, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
4iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland
Outi Kilpivaara
1Applied Tumor Genomics, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
2Department of Medical and Clinical Genetics, Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland
4iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland
6HUSLAB Laboratory of Genetics, HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland
7K. Albin Johansson Cancer Research Fellow, Foundation for the Finnish Cancer Institute, Helsinki, Finland

Article usage
Posted October 23, 2024.
Pathogenicity evaluation of coding germline variants identifies rare alleles enriched in hematological patients of a founder population
Jessica R. Koski, Laura Langohr, Tuulia Räisänen, Atte K. Lahtinen, Marja Hakkarainen, Caroline A. Heckman, Ulla Wartiovaara-Kautto, Esa Pitkänen, Outi Kilpivaara
medRxiv 2024.10.23.24315723; doi: https://doi.org/10.1101/2024.10.23.24315723
Pathogenicity evaluation of coding germline variants identifies rare alleles enriched in hematological patients of a founder population
Jessica R. Koski, Laura Langohr, Tuulia Räisänen, Atte K. Lahtinen, Marja Hakkarainen, Caroline A. Heckman, Ulla Wartiovaara-Kautto, Esa Pitkänen, Outi Kilpivaara
medRxiv 2024.10.23.24315723; doi: https://doi.org/10.1101/2024.10.23.24315723
Subject Area
Subject Areas
- Addiction Medicine (415)
- Allergy and Immunology (736)
- Anesthesia (216)
- Cardiovascular Medicine (3154)
- Dermatology (268)
- Emergency Medicine (468)
- Epidemiology (13120)
- Forensic Medicine (15)
- Gastroenterology (876)
- Genetic and Genomic Medicine (4944)
- Geriatric Medicine (456)
- Health Economics (758)
- Health Informatics (3110)
- Health Policy (1110)
- Hematology (415)
- HIV/AIDS (983)
- Medical Education (460)
- Medical Ethics (121)
- Nephrology (508)
- Neurology (4697)
- Nursing (249)
- Nutrition (695)
- Oncology (2422)
- Ophthalmology (689)
- Orthopedics (271)
- Otolaryngology (334)
- Pain Medicine (313)
- Palliative Medicine (88)
- Pathology (523)
- Pediatrics (1258)
- Primary Care Research (530)
- Public and Global Health (7263)
- Radiology and Imaging (1624)
- Respiratory Medicine (950)
- Rheumatology (464)
- Sports Medicine (408)
- Surgery (525)
- Toxicology (66)
- Transplantation (223)
- Urology (193)